Content
July 2015, Volume 38, Issue 7
- 611-620 DNA Barcoding and Pharmacovigilance of Herbal Medicines
by Hugo J. Boer & Mihael C. Ichim & Steven G. Newmaster
October 2014, Volume 37, Issue 10
- 743-759 Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum
by Jürgen Beckmann & Ulrich Hagemann & Priya Bahri & Andrew Bate & Ian Boyd & Gerald Dal Pan & Brian Edwards & I. Edwards & Kenneth Hartigan-Go & Marie Lindquist & John McEwen & Yola Moride & Sten Olsson & Shanthi Pal & Rachida Soulaymani-Bencheikh & Marco Tuccori & Claudia Vaca & Ian Wong - 761-764 Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet
by G. Norén - 765-770 Pharmacovigilance in China: Current Situation, Successes and Challenges
by Li Zhang & Lisa Wong & Ying He & Ian Wong - 771-776 Restrictive Reimbursement Policies: Bias Implications for Claims-Based Drug Safety Studies
by Joshua Gagne - 777-790 Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art
by Rave Harpaz & Alison Callahan & Suzanne Tamang & Yen Low & David Odgers & Sam Finlayson & Kenneth Jung & Paea LePendu & Nigam Shah - 791-804 The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis
by Jacqueline Flank & Lillian Sung & Christopher Dvorak & Wendy Spettigue & L. Dupuis - 805-813 Comparison of Pregnancy and Lactation Labeling for Attention-Deficit Hyperactivity Disorder Drugs Marketed in Australia, the USA, Denmark, and the UK
by Pernille Warrer & Lise Aagaard & Ebba Hansen - 815-829 Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events
by Agata Ptaszynska & Kristina Johnsson & Shamik Parikh & Tjerk Bruin & Anne Apanovitch & James List
September 2012, Volume 35, Issue 9
- 695-709 Early Investigation of QTc Liability
by Rashmi R. Shah & Joel Morganroth - 711-724 A Pathway to Improved Prospective Observational Post-Authorization Safety Studies
by Victor A. Kiri - 725-731 A Computerized Physician Order Entry Set Designed to Improve Safety of Intravenous Haloperidol Utilization
by Andrew J. Muzyk & Sarah K. Rivelli & Wei Jiang & Heather Heinz & Amber Rayfield & Jane P. Gagliardi - 733-743 Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice Records
by Andrew Tomlin & David Reith & Susan Dovey & Murray Tilyard - 745-758 Drug Interactions in Dying Patients
by Sebastian Frechen & Anna Zoeller & Klaus Ruberg & Raymond Voltz & Jan Gaertner - 759-767 Drug Fever
by Dominique Vodovar & Christine LeBeller & Bruno Mégarbane & Agnes Lillo-Le-Louet & Thomas Hanslik - 769-781 Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments
by Chen Wu & Chaim M. Bell & Walter P. Wodchis
December 2001, Volume 24, Issue 14
- 1019-1026 Technologies to Improve Immunisation Safety
by C. John Clements & Maria Teresa Aguado & Luis Jódar - 1027-1037 Benefits and Risks of Self Medication
by Carmel M. Hughes & James C. McElnay & Glenda F. Fleming - 1039-1053 Comparative Tolerability of First-Generation Selective Estrogen Receptor Modulators in Breast Cancer Treatment and Prevention
by Michèle G. Curtis - 1055-1063 Antimalarial Drugs in Systemic Lupus Erythematosus: Use in Pregnancy
by Miriam B. Borden & Ann L. Parke - 1065-1080 Asthma Medications and their Potential Adverse Effects in the Elderly
by Donald Mackenzie Newnham - 1081-1090 Adverse Drug Reactions Related to the Use of NSAIDs with a Focus on Nimesulide
by Anita Conforti & Roberto Leone & Ugo Moretti & Federico Mozzo & Giampaolo Velo
Printed from https://ideas.repec.org/s/spr/drugsa7.html